Market Overview

Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week, July 15

Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week, July 15
Read more about our latest Cannabis News! CANNABIS HOME

This story originally appeared on

Welcome to the Cannabis Countdown. In this week’s rendition we’ll recap and countdown the top 10 marijuana stock news stories for the week of July 8th – 14th, 2019.

Without further ado, let’s get started.

10. Introducing The New NYSE Pure-Play Cannabis ETF

It was announced earlier this week that the New York Stock Exchange (NYSE) listed a brand new cannabis ETF simply called ‘The Cannabis ETF’.

The new passively managed pure-play cannabis ETF trades on the NYSE Arca and currently holds positions in 35 North American cannabis stocks.

Check out the full list of 35 stocks from Canada and the United States.

Read full Cannabis ETF article

Read more Cannabis ETFs news & articles

9. Canopy Growth and CMHA Launch Initiative to Tackle Mental Health in Canada

The medical division of Canopy Growth (TSX: WEED) (NYSE: CGC), Spectrum Therapeutics, announced the company is joining forces with the Canadian Mental Health Association (CMHA) to develop educational content modules relating to cannabis in the workplace. This is the first time that a major cannabis company has partnered with a national mental health organization.

The 2 companies will collaborate on their new mental health initiative as part of CMHA’s ‘Not Myself Today‘ workplace mental health program.

Read full Canopy Growth article

Read more Canopy Growth news & articles

8. Tilray Imports GMP-Certified Standardized Medical Cannabis Oil into Ireland

Tilray (NASDAQ: TLRY) announced that it has successfully imported Good Manufacturing Practices (GMP)-certified finished medical cannabis oral solutions into Ireland intended for nationwide distribution.

Ireland becomes the 13th country with Tilray medical cannabis products as company continues global expansion in Europe and increases access to patients in need.

Read full Tilray article

Read more Tilray news & articles

7. CannTrust Whistleblower says Health Canada Would Never Have Found Unlicensed Rooms Without Him

A former CannTrust Holdings (NYSE: CTST) employee believes that had he not blown the whistle on his former employer, Health Canada would not have discovered that the cannabis producer was growing plants in five unlicensed rooms.

Nick Lalonde, who said he was responsible for the disposal of cannabis at a Pelham, Ont., greenhouse for nearly two years, wrote an email to Health Canada on June 14, detailing how CannTrust was allegedly violating regulations by growing cannabis in an unlicensed room. The company, Lalonde alleged in his email, took extensive measures, such as hanging white poly walls, to hide thousands of cannabis plants from Health Canada.

Read full CannTrust Whistleblower article

6. The Great Cannabis Executive Purge Continues

Boards are Telling Non-Performing and Shady CEOs to Buzz Off.

Investors have outgrown the era of excitement where anyone who took a cannabis company public got star treatment, and they want to see clean bottom line numbers with no conflicts of interest or shenanigans.

In light of recent news, we’ve put together the following roundup of some of the most notable departures of the chiefs of corporate cannabis.

Read full Cannabis CEO Purge article

5. Why American Cannabis Stocks Are Under Pressure

We think that the two negative surprises out of Canada this month from Canopy Growth (NYSE: CGC) and CannTrust (NYSE: CTST) have played a role in the weakness indirectly, but there are several factors that are also contributing.

First, as we have pointed out previously, several mergers have been delayed due to anti-trust reviews. We continue to think that these large mergers will go through, but the market appears to be concerned that they may not as evidenced by the massive 27% discount for Origin House (CSE: OH) (OTCQX: ORHOF) relative to the terms of its merger with Cresco Labs (CSE: CL) (OTCQX: CRLBF). The other delayed large transactions include Curaleaf (CSE: CURA) (OTCQX: CURLF), Harvest Health (CSE: HARV) (OTCQX: HRVSF) and MedMen (CSE: MMEN) (OTCQX: MMNFF).

Read full U.S. Stocks Under Pressure article

4. Bloodbath on Weed Street: One Man’s Fear is Another Man’s Opportunity

Linton’s Ouster and CannTrusts’ Dilemma Fuel Market Sell-Off.

  • The Holy Grail of Market Catalysts
  • Buy When There’s Blood in the Streets
  • Mr. Linton’s Ouster
  • Special Committee Forms to Put the ‘Trust’ Back in CannTrust
  • Fortune Favours the Brave

Read full Bloodbath on Weed Street article

3. CannTrust’s Pelham Greenhouse Fails Health Canada Audit, Company Begins Process of Putting the ‘Trust’ Back in ‘CannTrust’

CannTrust Holdings (NYSE: CTST) dropped a bombshell on investors when the company announced the results of their Health Canada compliance report. In the report, Health Canada notified CannTrust that their Pelham, Ontario greenhouse is not compliant with certain Health Canada regulations.

So what did CannTrust do to fail their Health Canada audit?

Read full CannTrust article

2. Former Canopy Growth CEO Bruce Linton Reveals Why he was Fired, His Next Move

It’s been a week since the surprise firing of the co-founder of the world’s largest marijuana company Canopy Growth (NYSE: CGC).

In that week, former CEO Bruce Linton has been reflecting on what brought the board of the company he co-founded to oust him and the conclusion he reached is simple: He thought he had more time to continue growing his baby.

Read full Bruce Linton article

1. CannTrust Pot Products Pulled From Ontario Stores Amid Health Canada Fracas

CannTrust Holdings’ recreational cannabis products have been pulled from the shelves of Canada’s biggest pot market, the latest blow to the company after Health Canada said it was non-compliant with certain regulations.

CannTrust’s shares have plunged almost 27% on the Toronto Stock Exchange since Monday when the company disclosed an inspection by Health Canada identified several unauthorized activities by the pot producer, such as producing thousands of kilograms of cannabis in unlicensed rooms before it had obtained the necessary approvals from the federal regulator.

Read full CannTrust article

Read more CannTrust news & articles

Image sourced from Pixabay

Read more about our latest Cannabis News! CANNABIS HOME

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Posted-In: cannabis industryCannabis Government News Regulations Markets ETFs General


Related Articles (CGC + CRLBF)

View Comments and Join the Discussion!
Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

FreightWaves NOW: The Effects Of Barry And What Carriers Need To Know

Eton Pharmaceuticals Shares Slammed After FDA Complete Response Letter